Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
26
BOLT Quote, Financials, Valuation and Earnings
Last price:
$5.80
Seasonality move
:
-23.31%
Day range:
$5.70 - $5.87
52-week range:
$5.20 - $15.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.14x
P/B ratio:
0.24x
Volume:
3.3K
Avg. volume:
24.3K
1-year change:
-61.2%
Market cap:
$11M
Revenue:
$7.7M
EPS (TTM):
-$33.40
Earnings Data
Next earnings date for BOLT
Aug 13
2025
Most recent earnings per share
-$5.80
Beat by $1.40
(May 12/2025)
Consensus Estimate
-$7.20
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BOLT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $751K | -- | -- | -$6.13 | -- |
| 08/13/2025 | Q2 | $819.8K | -- | -- | -$6.27 | -- |
| 05/12/2025 | Q1 | $767.5K | $1.2M | -$5.80 | -$7.20 | $1.40 |
| 03/24/2025 | Q4 | $790K | -- | -$8.40 | -$7.00 | -$1.40 |
| 11/12/2024 | Q3 | $1.3M | $1.1M | -$8.00 | -$7.90 | -$0.10 |
| 08/13/2024 | Q2 | $891.5K | $1.3M | -$11.20 | -$11.73 | $0.53 |
| 05/14/2024 | Q1 | $2.3M | $5.3M | -$5.60 | -$10.25 | $4.65 |
| 03/21/2024 | Q4 | $1.8M | $2.1M | -$9.40 | -$10.10 | $0.70 |
| 11/09/2023 | Q3 | $1.8M | $2.5M | -$8.60 | -$10.45 | $1.85 |
| 08/07/2023 | Q2 | $1.8M | $1.4M | -$9.60 | -$8.95 | -$0.65 |
| 05/11/2023 | Q1 | -- | $1.8M | -$9.00 | -- | -- |
| 03/29/2023 | Q4 | -- | $1.4M | -$10.60 | -- | -- |
| 11/09/2022 | Q3 | -- | $2.1M | -$11.60 | -- | -- |
| 08/10/2022 | Q2 | -- | $1.4M | -$12.20 | -- | -- |
| 05/12/2022 | Q1 | -- | $813K | -$12.80 | -- | -- |
| 03/30/2022 | Q4 | -- | $508K | -$14.60 | -- | -- |
| 11/09/2021 | Q3 | -- | $752K | -$12.60 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$12.80 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$22.80 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$19.49 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$14.30 | -- | -- |
| 06/30/2020 | Q2 | -- | $67K | -$15.81 | -- | -- |
| 03/31/2020 | Q1 | -- | $164K | -$12.34 | -- | -- |
| 12/31/2019 | Q4 | -- | $65K | -$13.38 | -- | -- |
Bolt Biotherapeutics Earnings Questions
-
How Much did Bolt Biotherapeutics Generate in Revenue Last Quarter?
Bolt Biotherapeutics reported $1.2M worth of top line sales in its most recent quarter.
-
Did Bolt Biotherapeutics Beat Earnings Last Quarter?
Bolt Biotherapeutics announced earnings per share of -$5.80 which represents a beat of analyst forecast a -$7.20 per share.
-
Is Bolt Biotherapeutics Profitable?
Bolt Biotherapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Bolt Biotherapeutics EPS Next Year?
Bolt Biotherapeutics's earnings are forecast to decrease from -$33.00 per share to -$30.00 per share next year representing a decrease of -27.07%.
-
When is Bolt Biotherapeutics's Earnings Date?
Bolt Biotherapeutics's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
